CClinicalTrials.gg
Not yet recruitingNCT07513272Updated Apr 7, 2026

EFFECT OF BALLS ON PAIN AND ANXIETY DURING VENIPUNCTURE IN CHILDREN

An interventional study of Soft ball and spiky ball in Venipuncture-related Pain and Anxiety, sponsored by Ankara University. Not yet recruiting. Open to participants aged 7 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-04-07.

Sponsored by Ankara University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
144
Allocation
Randomized
Ages
7 Years to 12 Years
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate whether using two different types of balls can reduce pain and anxiety during venipuncture in school-aged children (7-12 years) in a pediatric emergency setting. The main questions it aims to answer are:

Does squeezing a soft ball or a textured (ridged) ball during venipuncture reduce perceived pain compared to a control group? Does squeezing a soft ball or a textured (ridged) ball during venipuncture reduce situational anxiety compared to a control group?

Researchers will compare the soft ball, textured ball, and control groups to see if the type of ball affects children's pain and anxiety levels.

Participants will:

Complete a demographic and clinical information form. Use Wong-Baker Faces Pain Rating Scale (WBS) and Child Anxiety Scale-State (ÇAS-D) to report pain and anxiety before, during, and after venipuncture.

Squeeze either a soft or textured ball during venipuncture (for experimental groups) while control group children receive standard care without distraction.

02

Conditions studied

  • Venipuncture-related Pain and Anxiety

Keywords

  • pain
  • child
  • venipuncture
  • anxiety
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's planned enrollment of 144 is above the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Ankara University is the lead sponsor of 312 studies on the registry; 68 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Children aged 7-12 years. At least one prior experience of blood draw within the past year. Able to communicate in Turkish. Written informed consent obtained from both child and parents. No physical, auditory, intellectual, or neurological disabilities. No dermatological conditions affecting hand integrity. No analgesic, antipyretic, or anti-inflammatory drug use within the last 12 hours.

No acute pain reported before the procedure. No chronic illness causing regular invasive procedures or chronic pain.

Exclusion criteria

Exclusion Criteria:

Inability to complete the first blood draw. Holding another object during the procedure. Withdrawal from the study at any point. Not meeting any of the inclusion criteria listed above.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
144 participants (estimated)

Study arms

  • Experimental
    soft ball

    Participants will squeeze a soft, non-resistant ball with the hand opposite to the venipuncture site during blood draw to provide distraction and tactile stimulation.

    Other: Soft ball

  • Experimental
    spiky ball

    Participants will squeeze a textured (spiky), resistant ball with the hand opposite to the venipuncture site during blood draw to provide tactile stimulation and distraction.

    Other: spiky ball

  • No intervention
    Control

    Participants will undergo standard venipuncture care without the use of any ball or additional distraction intervention.

Interventions

  • OtherSoft ball

    Participants will squeeze a soft, non-resistant ball with the hand opposite to the venipuncture site during blood draw to provide distraction and tactile stimulation. The ball is easily compressible, returns to its original shape, and is safe for repeated use.

  • Otherspiky ball

    Participants will squeeze a textured (spiky), resistant ball with the hand opposite to the venipuncture site during blood draw to provide tactile stimulation and distraction. The ball has small rounded protrusions, offers resistance when squeezed, and is safe for repeated use.

06

What researchers measure

Primary outcomes

  1. Anxiety Level During Venipuncture

    Anxiety will be assessed using the Child Anxiety Scale-Situational before, during, and after venipuncture.

    Time frame: Immediately before, during, and immediately after venipuncture

  2. Pain Level During Venipuncture

    Pain will be assessed using the Wong-Baker Faces Pain Rating Scale (WBS) before, during, and after venipuncture.

    Time frame: Immediately before, during, and immediately after venipuncture

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Hjelmgren H, Ygge BM, Nordlund B, Andersson N. Nurses' experiences of blood sample collection from children: a qualitative study from Swedish paediatric hospital care. BMC Nurs. 2022 Mar 15;21(1):62. doi: 10.1186/s12912-022-00840-2. PubMed 35292007 ↗

Related links

Individual participant data

Plan to share: No — Individual participant data will not be shared to protect participant privacy and confidentiality.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07513272
Lead sponsor
Ankara University
Responsible party
Zeynep Yurdakul (PhD, Ankara Etlik City Hospital) — Principal investigator
First posted
Apr 7, 2026
Start date
May 1, 2026 (estimated)
Primary completion
Jul 31, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Apr 7, 2026

Study contacts

zeynep yurdakul, phd
Contact
zeyneppyurdakull@gmail.com
05545640036
aylin arıkan, phd
Contact
aylnarkn@hotmail.com

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion